A three-dimensional computer-generated image of a group of carbapenem-resistant Enterobacteriaceae bacteri, released by the Centers for Disease Control and Prevention. AP/Centers for Disease Control

“It’s like we’ve been under the safety of these magic bullets, these antibiotics for 80 years,” he said. "We don’t have to worry about anything. We’ve been invincible."

You don’t have to go to India to get a superbug. In Los Angeles, two people are dead and five patients are infected after being exposed to CRE during endoscopic procedures at Ronald Reagan UCLA Medical Center Hospital. Last week, UCLA notified another 179 patients that may have been exposed to the superbug while also undergoing the procedure.

The federal Centers for Disease Control and Prevention says the "nightmare bacteria" infects more than 9,000 people a year at health care facilities. Multiple American hospitals have seen superbug outbreaks in the last few years, and they believe the culprit may be duodenoscopes, a device with a camera on the end that's placed down the throat of a patient to investigate gastrointestinal complaints.

Now, two lawsuits obtained by America Tonight accuse Olympus Medical Systems, the maker of the scopes, of negligence, fraud and misrepresentation. The plaintiffs, 18-year-old Aaron Young and the family of a deceased 48-year-old California woman, say Olympus didn't provide effective cleaning protocols when it rolled out its latest version of the device.

According to the complaint, Young was exposed to a contaminated duodenoscope. Young was treated for the infection in 2014, but was then re-infected and is still at UCLA receiving treatment, according to Pete Kaufman, who’s representing Young and the family of the deceased UCLA patient.

In October 2014, the 48-year-old California woman, who underwent multiple medical procedures at UCLA, was also exposed to a dirty scope, according to the lawsuit. The lawsuit claims that the woman died because of that exposure.

The lawsuit claims that the makers failed to reevaluate the cleaning protocols when it introduced a redesigned model last year. Failing to update the cleaning protocols rendered the device defective, according to the filing.

"It appears what happened, the tweak was made to the device – something Olympus itself has described as a complete redesign – without adjusting the cleaning protocol," Kaufman said. "If that happened, Olympus was asleep at the wheel."